We describe a 71-year-old lady with end-stage renal failure on haemodialysis who developed vertebral discitis due to MRSA. She was intolerant of glycopeptide antibiotics and was treated successfully with oral linezolid for four weeks followed by oral combination therapy with doxycycline and fusidic acid for two weeks. Her antibiotic management and her clinical course is described, and we discuss the usefulness of the above antibiotics to treat MRSA infections affecting bone and vertebral discs in patients with renal failure.
Get full access to this article
View all access options for this article.
References
1.
TordaAJTGottliebBradburyR. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis 1995; 20:320–8.
2.
NichollsANEdwardStaphylococcal septicaemiaCatto GRD., endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J 1980; 56:642–8.
3.
GolperTAGSchulmanD’AgataEMC.Indications for vancomycin in dialysis patients. Semin Dial 2000; 13:389–92.
4.
GelfandMSClevelandKO.Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis. South Med J 2004; 97:593–7.
5.
MelzerMDGoldsmithGransdenW. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus bacteraemias. Clin Infect Dis 2000; 31:208–9.
6.
MoelleringRC.Linezolid: The First oxazolidinone antimicrobial. Ann Intern Med 2003; 138:135–42.
7.
PaladinoJA.Linezolid:An oxazolidinone antimicrobial agent. Am J Health-Syst Pharm 2002; 59:2413–25.
8.
BaileyEMMDFaberNafzigerDA.Linezolid for treatment of vancomycin-resistant enterococcal peritonitis. Am J Kidney Dis 2001; 38:E20.
9.
Gerson SL,Kaplan SL, Bruss JB Hematologic effects of linezolid: summary of clinical experience. Antimicrobial Agents and Chemotherapy 2002; 46:2723–6.
10.
LautenbachEEGRGRobinsonSerumKoornhof HJ.concentrationstissue of sodium fusidate in patients with chronic osteomyelitis and in normal volunteers. SAJS 1975; 13:21–32.
11.
BrownNMDSReevesMcMullinCM.The pharmacokinetics and protein-binding of fusidic acid in patients with severe renal failure requiring either haemodialysis or continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1997; 39:803–9.
12.
DaviesJPAldermanPA.Acute renal failure in association with fusidic acid. Int J Clin Pract 1997; 51:264.
13.
SaivinSHouinG. Clinical pharmacokinetics of doxycycline and minocycline. Clinical Pharmacokinetics 1988; 15:355–66.
14.
HeaneyDMinocyclineEknoyan G.kineticsdoxycycline in chronic renal failure. Clinical Pharmacology and Therapeutics 1978; 24:233–9.